Navigation Links
First at-home test for vasectomized men proves to be safe, accurate
Date:11/13/2008

CHARLOTTESVILLE, VA (November 13, 2008) In a report now available online and scheduled to be the cover story of the December 2008 issue of the Journal of Urology, University of Virginia Health System researcher John C. Herr, PhD and his colleagues have confirmed the accuracy and reliability of SpermCheck Vasectomy, the first FDA approved at-home immunodiagnostic test for detecting low concentrations of sperm.

Herr, a professor of Cell Biology and director of UVA's Center for Research in Contraceptive and Reproductive Health, discovered and patented the biomarker on which SpermCheck is based. The newly reported research consisted of a clinical trial and consumer study.

In the clinical trial, researchers used SpermCheck to evaluate a cohort of 144 post-vasectomy semen samples. The test achieved an accuracy rate of 96 percent in identifying whether sperm counts were greater or less than a threshold of 250,000 sperm per ml a level associated with little or no risk of causing pregnancy. SpermCheck proved to be 100 percent accurate in identifying whether sperm counts were greater or less than 384,000 sperm per ml.

According to the World Health Organization Manual on Semen Analysis, normal sperm counts range from 20,000,000/ml to as high as 200,000,000/ml. When the count is below 1,000,000/ml, there is only a remote chance of achieving pregnancy without assisted reproductive techniques such as intra-uterine insemination, in-vitro fertilization and intra-cytoplasmic sperm injection.

In the consumer study of SpermCheck, 109 lay volunteers demonstrated its ease of use. Volunteers obtained the correct or expected test result in every case and achieved a 97 percent correct response rate on a 20-question survey about the test.

Herr, who is now involved in commercializing SpermCheck through a start-up company, believes the product will make it easier for men to comply with post-vasectomy monitoring. Traditionally, th
'/>"/>

Contact: Ellen McKenna
ellenmckenna@virginia.edu
434-982-4490
University of Virginia Health System
Source:Eurekalert

Page: 1 2

Related biology news :

1. Washington University scientists first to sequence genome of cancer patient
2. First results from hospital trials testing
3. Scientists achieve first tracking of salmon from headwaters in Rockies through Pacific to Alaska
4. First comprehensive genomic study of common cold reveals new treatment targets
5. Synaptics Reports Record Results for First Quarter of Fiscal 2009
6. Study of polar dinosaur migration questions whether dinosaurs were truly the first great migrators
7. Volcanoes may have provided sparks and chemistry for first life
8. Alzheimers disease research attracts first partner
9. Synaptics to Report First Quarter Results on October 23
10. Digital zebrafish embryo provides the first complete developmental blueprint of a vertebrate
11. Complete Genomics launches, becomes worlds first large-scale human genome sequencing company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2009)... , , A good wine needs to ripen. But it,s a long...rapevines have to overcome all kinds of obstacles.... crops, not to mention the wide variety of pests t... louse or the rust mite, fungi such as mildew, or ...V for short) can give the vines a hard time. The G...
(Date:7/2/2009)...rates its birth on the 4th of July, University of ...bean coral reef nursery scientists will be celebra...c Administration (NOAA) today announced that The N...lkhorn coral recovery project, including Lirman,s ...pport from the American Recovery and Reinvestment ...
(Date:7/1/2009)...ssociated with the formation of metastases in colo... Center for Molecular Medicine (MDC) Berlin-Buch a...ve identified 115 genes that are disregulated both...e future, their findings may help identify patient...troenterology 2009, doi:10.1053/j.gastro.2009.03....
(Date:7/1/2009)...for repairing DNA strands damaged by oxidation lea...l evidence that such stress contributes to the dev...ent study* in DNA Repair by researchers at the N...T), Oregon Health and Science University (OHSU) an...M). , Although all cells need oxygen to survive,...
Breaking Biology News(10 mins):Virus-resistant grapevines 2Nursery programs for corals receive TLC from NOAA this Independence Day 2Colorectal cancer 2Genetically engineered mice yield clues to 'knocking out' cancer 2Galderma announces approval for Differin gel 0 1 percent in Japan 24153 1Galderma announces approval for Differin gel 0 1 percent in Japan 24153 2Protein transports nutrients believed to protect against eye disease 4086 1Protein transports nutrients believed to protect against eye disease 4086 2Protein transports nutrients believed to protect against eye disease 4086 3Low Fat Milk OK for Some Toddlers 24150 1Low Fat Milk OK for Some Toddlers 24150 2Aethons Train Themed Delivery Robot Available To Childrens Hospitals Nationwide 24147 1Aethons Train Themed Delivery Robot Available To Childrens Hospitals Nationwide 24147 2
...condition of the oceans, their significance as the...n, and their impact on the climate will be at the ...k on the ocean, at the Euroscience Open Forum (ESO...r will be on utilisation and monitoring of coastal... and society. Friedhelm Schröder and Wilhelm Peter...
...dern genomic tools, it,s a daunting task to find a...lies in being able to say not just when and how a ...c change translated into real-world dominance of o...ogists, using an ingenious experiment that forced ...evolutionary dominance, today offer the first glim...
...t St. Jude Children,s Research Hospital have annou... against one antigenic variant of the avian influe...ariants of the virus. Vaccines based on this model...se during a pandemic (worldwide epidemic) until a ...t the variant causing the outbreak, the researcher...
... against cancer, antisense drugs, which prevent ge...that cause cancer, have the promise to be more eff...velopment of these new drugs has been slow. , Usin... at Northwestern University now have demonstrated ...utperform conventional antisense agents. The findi...
Other Biology News:A new look at the state of the oceans 2A new look at the state of the oceans 3Ready, set, mutate?and may the best microbe win 2Ready, set, mutate?and may the best microbe win 3Scientists to employ Arctic ice and polar bears to protect diversity of world's crops 2Gold nanoparticles could improve antisense cancer drugs 2
(Date:7/1/2009)...MADISON, Wis., July 1 Cellular D...ced today a significant expansion of their existin...r their potential to cause cardiotoxicity, or dama...s to enhance drug safety testing in order to bring...nder this agreement, CDI will supply purified card...
(Date:7/1/2009)...SAN DIEGO, July 1 Biocept, Inc. ("...nounced today the appointment of Daniel H. Petree ...leased to welcome Dan and Faye to our Board. Their...to our next stage of development," said Stephen M.... been a principal of Wilson Boyles and Company, a ...
(Date:7/1/2009)...Single-dose of investigational sustained follicle ...tions of follitropin beta given over a one week pe...PRNewswire-FirstCall/ -- Schering-Plough Corp., (N...e III ENGAGE clinical trial demonstrating that a s...the class of sustained follicle stimulants, achiev...
(Date:7/1/2009)...NEW YORK, July 1 NeoStem... has raised additional gross funds of over $4 mill...e funds, together with the $11 million private pla...pril 13, 2009, bring the total investment obtained...r $15 million. In addition, affiliates of Suzhou ...
Breaking Biology Technology:Cellular Dynamics International and Roche Expand Existing Cardiotoxicity Screening Agreement 2Cellular Dynamics International and Roche Expand Existing Cardiotoxicity Screening Agreement 3Biocept, Inc. Announces Two New Director Appointments 2Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 2Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 3Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 4Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 5Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 6Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 7Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 8Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 9NeoStem Raises Additional Funds from Principals of Suzhou Erye Pharmaceuticals Company Ltd. and U.S. Institutional and Private Investors, Bringing the Total Recent Financings to Over $15 Million; Funds Will Support Expansion Activities in the United State 2NeoStem Raises Additional Funds from Principals of Suzhou Erye Pharmaceuticals Company Ltd. and U.S. Institutional and Private Investors, Bringing the Total Recent Financings to Over $15 Million; Funds Will Support Expansion Activities in the United State 3
... years in tax credits , ,MADISON The future of v...cussed at an economic development breakfast panel ...ison Small Business Development Center at the MG&E...nt specialists, from both the public and private s...t legislation, Act 255. , ,State Secretary of Comm...
...y Council has published the first-ever magazine ab... publication highlights the states research base, ...lity of life, key contacts and the I-Q Corridor th...ul. , ,The Wisconsin Technology Network has arran... The Smart Choice, over the next few weeks. Today...
...r of automotive systems and facility management co... examine its processes. Jim Hayes, the companys de...ge from Intelligenxia, Inc. , a Florida-based com...earch unstructured text for valuable data. , ,The ...es and looks for patterns in data such as surveys ...
..., ,Your business card reads project manager. You j...en to training, regularly participate in seminars ...w (osmosis). The methodology on your desk is almos...ters. Ill bet you could recite the cost control se...ring your walls than new paint. Youve managed coun...
Other Biology Technology:The impact of ACT 255 on the future of high-tech investment in Wisconsin 2Life Sciences: Wisconsin - The Smart Choice Part Two 2Life Sciences: Wisconsin - The Smart Choice Part Two 3Life Sciences: Wisconsin - The Smart Choice Part Two 4Life Sciences: Wisconsin - The Smart Choice Part Two 5Life Sciences: Wisconsin - The Smart Choice Part Two 6Life Sciences: Wisconsin - The Smart Choice Part Two 7Part 5 Project Performance Get on the path to continuous improvement 2Part 5 Project Performance Get on the path to continuous improvement 3Part 5 Project Performance Get on the path to continuous improvement 4